Latest Breaking News On - Precision oncology initiative - Page 1 : comparemela.com

Invitae Corporation (NYSE:NVTA) Q1 2023 Earnings Call Transcript

Operator: Hello, everyone, and welcome to the Invitae First Quarter 2023 Financial Results Conference Call. My name is Emily, and I will be your conference coordinator today.

United statesSan antonioCharles swantonKen kightMatthew sykesHoki lukPuneet soudaRobert daberKen knightW michael kornInvitae corpWomen healthInvitae corporationUniversity college londonPrecision oncology initiativeGoldman sachs

Invitae (NVTA) Q1 2023 Earnings Call Transcript

NVTA earnings call for the period ending March 31, 2023.

United statesSan antonioMatthew sykesRobert daberKen knightPuneet soudaCharles swantonW michael kornHoki lukMatthew sykes goldman sachsPrecision oncology initiativeUniversity college londonGoldman sachsWomen healthInvestor relationsRoxi wen

Invitae Appoints Dr W Michael Korn as Chief Medical Officer for Oncology

/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of W. Michael Korn, M.D., as its chief medical.

West germanW michael kornAmanda mcqueryRobert nussbaumLinkedin invitaePrecision oncology initiativeYork stock exchange rulePhilipps university marburgUniversity hospital essenExchange commissionInvitae corporationDivision of hematology oncologyCaris life sciencesUniversity of california san franciscoGerman cancer centerCaris life

InVitae (NVTA) Appoints Dr W Michael Korn as Chief Medical Officer for Oncology

InVitae (NVTA) Appoints Dr W Michael Korn as Chief Medical Officer for Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

West germanW michael kornRobert nussbaumPrecision oncology initiativeYork stock exchange rulePhilipps university marburgUniversity hospital essenDivision of hematology oncologyCaris life sciencesUniversity of california san franciscoGerman cancer centerCaris lifeCalifornia san franciscoMolecular tumor boardWest german cancer centerUniversity hospital